Oncology Coding Break – Prostate SSDI: Number of Cores Positive and Examined

Oncology, Oncology Coding Break, Registry Education

<a href="https://www.registrypartners.com/author/patricia-fordham/" target="_self">Patricia Fordham</a>

Patricia Fordham

Quality Consultant

Published/Updated Date: June 24, 2024

In our quality reviews, we often encounter confusion regarding how to code two SSDI fields for Prostate: Number of Cores Positive and Number of Cores Examined. This confusion typically arises when there is a discrepancy between the pathology report’s final diagnosis and the gross description, or between the dictated physician procedure report and the pathology report.

To prevent errors in coding, it is essential to prioritize the pathology report’s final diagnosis, followed by the gross description. If the pathology report is available for review, it should be used as the primary source document for coding the number of cores positive and examined, as specified in the SSDI Manual.

During this Oncology Coding Break, we will:

  • Discuss the two fields in detail
  • Provide clarification on the use of code X6 (positive cores, unknown how many)
  • Walk through case examples, reviewing both the pathology report final diagnosis and the gross description

Join us for this session to enhance your understanding and accuracy in coding these fields.

Don’t miss out! Download the presentation as a PDF to have all the information at your fingertips.

Related

How AI Is Changing Registry Workflows

How AI Is Changing Registry Workflows

Artificial intelligence is quickly becoming part of healthcare operations. As registry programs face increasing case complexity, growing documentation requirements, staffing challenges, and pressure to deliver reliable data more efficiently, organizations are...

Childhood Cancer Awareness Month: Why Every Case Matters

Childhood Cancer Awareness Month: Why Every Case Matters

In September, Childhood Cancer Awareness Month draws attention to the children and their families who are affected by cancer and to the ongoing need for research, treatment advances, and support. It also provides a chance to acknowledge something more invisible. The...

Stay in Touch

Get our latest articles, registry insights, and company news straight to your inbox.

This field is for validation purposes and should be left unchanged.